Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.

A groundbreaking study at Rabin Medical Center suggests prostate cancer patients may need only two radiation doses, ...

PROSTATE cancer has become the most common form of the disease in Britain for the first time. Analysis of NHS figures by ...

ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action Convening, a national gathering committed to strengthening ...

For many cancer patients, hair loss is one of the most distressing side effects of their therapy. Increasingly, they have ...